The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Canine Arthritis Therapeutics Market Research Report 2025
Synopsis
The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort.
The global Canine Arthritis Therapeutics market was valued at US$ 2391 million in 2023 and is anticipated to reach US$ 3185.9 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
This report aims to provide a comprehensive presentation of the global market for Canine Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Arthritis Therapeutics.
Report Scope
The Canine Arthritis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Canine Arthritis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Arthritis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Elanco
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Stem Cell Therapy
Segment by Application
Veterinary Hospitals and Clinics
Retail Pharmacies
Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Canine Arthritis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort.
The global Canine Arthritis Therapeutics market was valued at US$ 2391 million in 2023 and is anticipated to reach US$ 3185.9 million by 2030, witnessing a CAGR of 4.2% during the forecast period 2024-2030.
The Animal Healthcare market is primarily driven by the increasing awareness about animal health and well-being, coupled with the rising prevalence of various animal diseases. Pet ownership has grown, leading to higher demand for veterinary services and products. Additionally, the growth of the livestock industry to meet global food demand further boosts the need for animal healthcare products. Advances in veterinary medicine and technology are also driving market growth, enabling better diagnosis, treatment, and preventive care for animals. However, challenges include regulatory complexities and the high cost of certain treatments, which can hinder accessibility for some pet owners or farmers. Striking a balance between quality care and affordability is crucial for the sustainable growth of the animal healthcare market.
This report aims to provide a comprehensive presentation of the global market for Canine Arthritis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Arthritis Therapeutics.
Report Scope
The Canine Arthritis Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Canine Arthritis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Arthritis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Elanco
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Stem Cell Therapy
Segment by Application
Veterinary Hospitals and Clinics
Retail Pharmacies
Drug Stores
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Canine Arthritis Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Arthritis Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Opioids
1.2.4 Stem Cell Therapy
1.3 Market by Application
1.3.1 Global Canine Arthritis Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Veterinary Hospitals and Clinics
1.3.3 Retail Pharmacies
1.3.4 Drug Stores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Arthritis Therapeutics Market Perspective (2019-2030)
2.2 Canine Arthritis Therapeutics Growth Trends by Region
2.2.1 Global Canine Arthritis Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Canine Arthritis Therapeutics Historic Market Size by Region (2019-2024)
2.2.3 Canine Arthritis Therapeutics Forecasted Market Size by Region (2025-2030)
2.3 Canine Arthritis Therapeutics Market Dynamics
2.3.1 Canine Arthritis Therapeutics Industry Trends
2.3.2 Canine Arthritis Therapeutics Market Drivers
2.3.3 Canine Arthritis Therapeutics Market Challenges
2.3.4 Canine Arthritis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Arthritis Therapeutics Players by Revenue
3.1.1 Global Top Canine Arthritis Therapeutics Players by Revenue (2019-2024)
3.1.2 Global Canine Arthritis Therapeutics Revenue Market Share by Players (2019-2024)
3.2 Global Canine Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Canine Arthritis Therapeutics Revenue
3.4 Global Canine Arthritis Therapeutics Market Concentration Ratio
3.4.1 Global Canine Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Arthritis Therapeutics Revenue in 2023
3.5 Canine Arthritis Therapeutics Key Players Head office and Area Served
3.6 Key Players Canine Arthritis Therapeutics Product Solution and Service
3.7 Date of Enter into Canine Arthritis Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Arthritis Therapeutics Breakdown Data by Type
4.1 Global Canine Arthritis Therapeutics Historic Market Size by Type (2019-2024)
4.2 Global Canine Arthritis Therapeutics Forecasted Market Size by Type (2025-2030)
5 Canine Arthritis Therapeutics Breakdown Data by Application
5.1 Global Canine Arthritis Therapeutics Historic Market Size by Application (2019-2024)
5.2 Global Canine Arthritis Therapeutics Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Canine Arthritis Therapeutics Market Size (2019-2030)
6.2 North America Canine Arthritis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Canine Arthritis Therapeutics Market Size by Country (2019-2024)
6.4 North America Canine Arthritis Therapeutics Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Canine Arthritis Therapeutics Market Size (2019-2030)
7.2 Europe Canine Arthritis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Canine Arthritis Therapeutics Market Size by Country (2019-2024)
7.4 Europe Canine Arthritis Therapeutics Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Canine Arthritis Therapeutics Market Size (2019-2030)
8.2 Asia-Pacific Canine Arthritis Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2019-2024)
8.4 Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Canine Arthritis Therapeutics Market Size (2019-2030)
9.2 Latin America Canine Arthritis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Canine Arthritis Therapeutics Market Size by Country (2019-2024)
9.4 Latin America Canine Arthritis Therapeutics Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Arthritis Therapeutics Market Size (2019-2030)
10.2 Middle East & Africa Canine Arthritis Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2019-2024)
10.4 Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Canine Arthritis Therapeutics Introduction
11.1.4 Boehringer Ingelheim Revenue in Canine Arthritis Therapeutics Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Zoetis Inc
11.2.1 Zoetis Inc Company Detail
11.2.2 Zoetis Inc Business Overview
11.2.3 Zoetis Inc Canine Arthritis Therapeutics Introduction
11.2.4 Zoetis Inc Revenue in Canine Arthritis Therapeutics Business (2019-2024)
11.2.5 Zoetis Inc Recent Development
11.3 Vetoquinol S.A.
11.3.1 Vetoquinol S.A. Company Detail
11.3.2 Vetoquinol S.A. Business Overview
11.3.3 Vetoquinol S.A. Canine Arthritis Therapeutics Introduction
11.3.4 Vetoquinol S.A. Revenue in Canine Arthritis Therapeutics Business (2019-2024)
11.3.5 Vetoquinol S.A. Recent Development
11.4 Elanco
11.4.1 Elanco Company Detail
11.4.2 Elanco Business Overview
11.4.3 Elanco Canine Arthritis Therapeutics Introduction
11.4.4 Elanco Revenue in Canine Arthritis Therapeutics Business (2019-2024)
11.4.5 Elanco Recent Development
11.5 Aratana Therapeutics Inc
11.5.1 Aratana Therapeutics Inc Company Detail
11.5.2 Aratana Therapeutics Inc Business Overview
11.5.3 Aratana Therapeutics Inc Canine Arthritis Therapeutics Introduction
11.5.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Therapeutics Business (2019-2024)
11.5.5 Aratana Therapeutics Inc Recent Development
11.6 Norbrook Laboratories Limited
11.6.1 Norbrook Laboratories Limited Company Detail
11.6.2 Norbrook Laboratories Limited Business Overview
11.6.3 Norbrook Laboratories Limited Canine Arthritis Therapeutics Introduction
11.6.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Therapeutics Business (2019-2024)
11.6.5 Norbrook Laboratories Limited Recent Development
11.7 VetStem Biopharma
11.7.1 VetStem Biopharma Company Detail
11.7.2 VetStem Biopharma Business Overview
11.7.3 VetStem Biopharma Canine Arthritis Therapeutics Introduction
11.7.4 VetStem Biopharma Revenue in Canine Arthritis Therapeutics Business (2019-2024)
11.7.5 VetStem Biopharma Recent Development
11.8 Dechra Pharmaceuticals Plc
11.8.1 Dechra Pharmaceuticals Plc Company Detail
11.8.2 Dechra Pharmaceuticals Plc Business Overview
11.8.3 Dechra Pharmaceuticals Plc Canine Arthritis Therapeutics Introduction
11.8.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Therapeutics Business (2019-2024)
11.8.5 Dechra Pharmaceuticals Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Canine Arthritis Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Non-Steroidal Anti-Inflammatory Drugs
Table 3. Key Players of Opioids
Table 4. Key Players of Stem Cell Therapy
Table 5. Global Canine Arthritis Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Canine Arthritis Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Canine Arthritis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Canine Arthritis Therapeutics Market Share by Region (2019-2024)
Table 9. Global Canine Arthritis Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Canine Arthritis Therapeutics Market Share by Region (2025-2030)
Table 11. Canine Arthritis Therapeutics Market Trends
Table 12. Canine Arthritis Therapeutics Market Drivers
Table 13. Canine Arthritis Therapeutics Market Challenges
Table 14. Canine Arthritis Therapeutics Market Restraints
Table 15. Global Canine Arthritis Therapeutics Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Canine Arthritis Therapeutics Market Share by Players (2019-2024)
Table 17. Global Top Canine Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Therapeutics as of 2023)
Table 18. Ranking of Global Top Canine Arthritis Therapeutics Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Canine Arthritis Therapeutics Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Canine Arthritis Therapeutics Product Solution and Service
Table 22. Date of Enter into Canine Arthritis Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Canine Arthritis Therapeutics Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Canine Arthritis Therapeutics Revenue Market Share by Type (2019-2024)
Table 26. Global Canine Arthritis Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Canine Arthritis Therapeutics Revenue Market Share by Type (2025-2030)
Table 28. Global Canine Arthritis Therapeutics Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Canine Arthritis Therapeutics Revenue Market Share by Application (2019-2024)
Table 30. Global Canine Arthritis Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Canine Arthritis Therapeutics Revenue Market Share by Application (2025-2030)
Table 32. North America Canine Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Canine Arthritis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Canine Arthritis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Canine Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Canine Arthritis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Canine Arthritis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Canine Arthritis Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Canine Arthritis Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Canine Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Canine Arthritis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Canine Arthritis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Canine Arthritis Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Canine Arthritis Therapeutics Market Size by Country (2025-2030) & (US$ Million)
Table 47. Boehringer Ingelheim Company Detail
Table 48. Boehringer Ingelheim Business Overview
Table 49. Boehringer Ingelheim Canine Arthritis Therapeutics Product
Table 50. Boehringer Ingelheim Revenue in Canine Arthritis Therapeutics Business (2019-2024) & (US$ Million)
Table 51. Boehringer Ingelheim Recent Development
Table 52. Zoetis Inc Company Detail
Table 53. Zoetis Inc Business Overview
Table 54. Zoetis Inc Canine Arthritis Therapeutics Product
Table 55. Zoetis Inc Revenue in Canine Arthritis Therapeutics Business (2019-2024) & (US$ Million)
Table 56. Zoetis Inc Recent Development
Table 57. Vetoquinol S.A. Company Detail
Table 58. Vetoquinol S.A. Business Overview
Table 59. Vetoquinol S.A. Canine Arthritis Therapeutics Product
Table 60. Vetoquinol S.A. Revenue in Canine Arthritis Therapeutics Business (2019-2024) & (US$ Million)
Table 61. Vetoquinol S.A. Recent Development
Table 62. Elanco Company Detail
Table 63. Elanco Business Overview
Table 64. Elanco Canine Arthritis Therapeutics Product
Table 65. Elanco Revenue in Canine Arthritis Therapeutics Business (2019-2024) & (US$ Million)
Table 66. Elanco Recent Development
Table 67. Aratana Therapeutics Inc Company Detail
Table 68. Aratana Therapeutics Inc Business Overview
Table 69. Aratana Therapeutics Inc Canine Arthritis Therapeutics Product
Table 70. Aratana Therapeutics Inc Revenue in Canine Arthritis Therapeutics Business (2019-2024) & (US$ Million)
Table 71. Aratana Therapeutics Inc Recent Development
Table 72. Norbrook Laboratories Limited Company Detail
Table 73. Norbrook Laboratories Limited Business Overview
Table 74. Norbrook Laboratories Limited Canine Arthritis Therapeutics Product
Table 75. Norbrook Laboratories Limited Revenue in Canine Arthritis Therapeutics Business (2019-2024) & (US$ Million)
Table 76. Norbrook Laboratories Limited Recent Development
Table 77. VetStem Biopharma Company Detail
Table 78. VetStem Biopharma Business Overview
Table 79. VetStem Biopharma Canine Arthritis Therapeutics Product
Table 80. VetStem Biopharma Revenue in Canine Arthritis Therapeutics Business (2019-2024) & (US$ Million)
Table 81. VetStem Biopharma Recent Development
Table 82. Dechra Pharmaceuticals Plc Company Detail
Table 83. Dechra Pharmaceuticals Plc Business Overview
Table 84. Dechra Pharmaceuticals Plc Canine Arthritis Therapeutics Product
Table 85. Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Therapeutics Business (2019-2024) & (US$ Million)
Table 86. Dechra Pharmaceuticals Plc Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Arthritis Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Canine Arthritis Therapeutics Market Share by Type: 2023 VS 2030
Figure 3. Non-Steroidal Anti-Inflammatory Drugs Features
Figure 4. Opioids Features
Figure 5. Stem Cell Therapy Features
Figure 6. Global Canine Arthritis Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Canine Arthritis Therapeutics Market Share by Application: 2023 VS 2030
Figure 8. Veterinary Hospitals and Clinics Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Drug Stores Case Studies
Figure 11. Canine Arthritis Therapeutics Report Years Considered
Figure 12. Global Canine Arthritis Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Canine Arthritis Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Canine Arthritis Therapeutics Market Share by Region: 2023 VS 2030
Figure 15. Global Canine Arthritis Therapeutics Market Share by Players in 2023
Figure 16. Global Top Canine Arthritis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Canine Arthritis Therapeutics as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Canine Arthritis Therapeutics Revenue in 2023
Figure 18. North America Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Canine Arthritis Therapeutics Market Share by Country (2019-2030)
Figure 20. United States Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Canine Arthritis Therapeutics Market Share by Country (2019-2030)
Figure 24. Germany Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Canine Arthritis Therapeutics Market Share by Region (2019-2030)
Figure 32. China Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Canine Arthritis Therapeutics Market Share by Country (2019-2030)
Figure 40. Mexico Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Canine Arthritis Therapeutics Market Share by Country (2019-2030)
Figure 44. Turkey Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Canine Arthritis Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Boehringer Ingelheim Revenue Growth Rate in Canine Arthritis Therapeutics Business (2019-2024)
Figure 47. Zoetis Inc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2019-2024)
Figure 48. Vetoquinol S.A. Revenue Growth Rate in Canine Arthritis Therapeutics Business (2019-2024)
Figure 49. Elanco Revenue Growth Rate in Canine Arthritis Therapeutics Business (2019-2024)
Figure 50. Aratana Therapeutics Inc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2019-2024)
Figure 51. Norbrook Laboratories Limited Revenue Growth Rate in Canine Arthritis Therapeutics Business (2019-2024)
Figure 52. VetStem Biopharma Revenue Growth Rate in Canine Arthritis Therapeutics Business (2019-2024)
Figure 53. Dechra Pharmaceuticals Plc Revenue Growth Rate in Canine Arthritis Therapeutics Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
